| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Christoph Stein | Q41923879 |
| Halina Machelska | Q42839465 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 860-881 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Pharmacological Reviews | Q2085079 |
| P1476 | title | Modulation of peripheral sensory neurons by the immune system: implications for pain therapy | |
| P478 | volume | 63 |
| Q39173836 | A randomized, controlled, clinical pilot study assessing the analgesic effect of morphine applied topically onto split-thickness skin wounds |
| Q37322206 | Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides |
| Q59800497 | Advances in Achieving Opioid Analgesia Without Side Effects |
| Q38615910 | Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels. |
| Q46315880 | Antinociceptive and anti-inflammatory activities of leaf extracts from Annona tomentosa R.E.Fr. |
| Q41702445 | Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1. |
| Q52630975 | CO-EXPRESSION OF μ AND ∂ OPIOID RECEPTORS BY MOUSE COLONIC NOCICEPTORS. |
| Q96122272 | Chemoenzymatic synthesis and pharmacological evaluation of enantiomerically pure quinoline-based κ-opioid receptor (KOR) agonists |
| Q38852117 | Chemogenetic Inhibition of Pain Neurons in a Mouse Model of Osteoarthritis |
| Q51734645 | Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay. |
| Q91891295 | Current strategies toward safer mu opioid receptor drugs for pain management |
| Q42141438 | Cutaneous nociceptors lack sensitisation, but reveal μ-opioid receptor-mediated reduction in excitability to mechanical stimulation in neuropathy |
| Q37627969 | Cytotoxic T cells modulate inflammation and endogenous opioid analgesia in chronic arthritis |
| Q33811673 | Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn |
| Q34431119 | Denatured G-protein coupled receptors as immunogens to generate highly specific antibodies |
| Q41038985 | Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain |
| Q64249807 | Dose-Dependent Effect of Hyperbaric Oxygen Treatment on Burn-Induced Neuropathic Pain in Rats |
| Q64097296 | Electroacupuncture decreases Netrin-1-induced myelinated afferent fiber sprouting and neuropathic pain through μ-opioid receptors |
| Q64896289 | Enteric Glia: A New Player in Abdominal Pain. |
| Q38213379 | Fractalkine/CX3CR1 signaling during neuropathic pain |
| Q89900040 | IL-4 induces M2 macrophages to produce sustained analgesia via opioids |
| Q48203635 | Inflammatory-linked changes in CpG island methylation of three opioid peptide genes in a rat model for pain. |
| Q92559902 | Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression |
| Q44340786 | Mu and delta opioid receptor knockout mice show increased colonic sensitivity. |
| Q28533332 | Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice |
| Q60947326 | Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve Injury |
| Q41386992 | Musculoskeletal pain |
| Q38288354 | Neonatal pain: What's age got to do with it? |
| Q34304397 | Noradrenergic reuptake inhibition in the treatment of pain |
| Q90479657 | Opioid Receptors in Immune and Glial Cells-Implications for Pain Control |
| Q38318330 | Opioid and chemokine receptor crosstalk: a promising target for pain therapy? |
| Q55336105 | Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist. |
| Q38166805 | Opioids for the treatment of arthritis pain |
| Q33608432 | Peripheral gating of pain signals by endogenous lipid mediators |
| Q92052810 | Peripheral neurons: Master regulators of skin and mucosal immune response |
| Q35614442 | Peripherally applied opioids for postoperative pain: evidence of an analgesic effect? A systematic review and meta-analysis. |
| Q33870260 | Polyglycerol-opioid conjugate produces analgesia devoid of side effects |
| Q93048221 | Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain |
| Q36204562 | Sensory Neuropeptides and Endogenous Opioids Expression in Human Dental Pulp with Asymptomatic Inflammation: In Vivo Study |
| Q41714041 | Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway |
| Q41971654 | Targeting pain and inflammation by peripherally acting opioids |
| Q41962056 | Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions |
| Q41923805 | The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia |
| Q96609788 | The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides |
| Q38954072 | The effect of preoperative submucosal administration of tramadol on the success rate of inferior alveolar nerve block on mandibular molars with symptomatic irreversible pulpitis: a randomized, double-blind placebo-controlled clinical trial. |
| Q35650317 | The opioid peptide dynorphin A induces leukocyte responses via integrin Mac-1 (αMβ2, CD11b/CD18). |
| Q50182799 | Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice |
| Q89059638 | Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators |
| Q64081722 | Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review |
| Q56990699 | Towards safer and more effective analgesia |
| Q92515547 | Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion |
| Q57466905 | Why mu-opioid agonists have less analgesic efficacy in neuropathic pain? |
| Q84970740 | [Neuroimmune connections in inflammation and pain. ImmunoPain] |
| Q57095558 | and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice |
Search more.